Literature DB >> 9750909

The epidemiology of the primary dystonias in the north of England.

P O Duffey1, A G Butler, M R Hawthorne, M P Barnes.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9750909

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  13 in total

Review 1.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Task-specific dystonias: a review.

Authors:  Diego Torres-Russotto; Joel S Perlmutter
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

3.  Depression in focal, segmental and generalized dystonia.

Authors:  L Lewis; A Butler; M Jahanshahi
Journal:  J Neurol       Date:  2008-11-13       Impact factor: 4.849

4.  A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins.

Authors:  Joohi Jimenez-Shahed
Journal:  Neuropsychiatr Dis Treat       Date:  2011-12-23       Impact factor: 2.570

5.  A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom.

Authors:  Mireia Raluy-Callado; Sylvie Gabriel; Jérôme Dinet; Meng Wang; Radek Wasiak
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-09       Impact factor: 2.570

6.  Clinical and Phenomenological Characteristics of Patients with Task-Specific Lingual Dystonia: Possible Association with Occupation.

Authors:  Kazuya Yoshida
Journal:  Front Neurol       Date:  2017-12-11       Impact factor: 4.003

7.  Epidemiology of benign essential blepharospasm: A nationwide population-based retrospective study in Taiwan.

Authors:  Yng Sun; Pei-Jhen Tsai; Chin-Liang Chu; Wei-Chun Huang; Youn-Shen Bee
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

8.  Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

9.  Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis.

Authors:  Gavin Charlesworth; Vincent Plagnol; Kira M Holmström; Jose Bras; Una-Marie Sheerin; Elisavet Preza; Ignacio Rubio-Agusti; Mina Ryten; Susanne A Schneider; Maria Stamelou; Daniah Trabzuni; Andrey Y Abramov; Kailash P Bhatia; Nicholas W Wood
Journal:  Am J Hum Genet       Date:  2012-11-29       Impact factor: 11.025

Review 10.  Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.

Authors:  Masamitsu Hyodo; Kento Asano; Asuka Nagao; Kahori Hirose; Maya Nakahira; Saori Yanagida; Noriko Nishizawa
Journal:  Toxins (Basel)       Date:  2021-11-25       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.